Lactobacillus brevis alleviates the progress of hepatocellular carcinoma and type 2 diabetes in mice model via interplay of gut microflora, bile acid and NOTCH 1 signaling
- 2023-05-10
- Clinical Trial
- Frontiers in Immunology 14
- Shujia Chen
- P. Han
- Qian Zhang
- Peiyan Liu
- Jie Liu
- Lili Zhao
- Lianyi Guo
- Jia Li
- PubMed: 37234174
- DOI: 10.3389/fimmu.2023.1179014
- Low evidence
- Animal Study
Accumulating evidence shows that Lactobacillus brevis can improve blood glucose and body weight of the T2DM mice model...
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes